No I'm actually not Prof Ian Frazer but thought the nic was in good jest...I'm interested in a number areas of oncology diagnosis and treatment
The ovarian cancer diagnosis space whilst highly interesting is a very difficult area to say the least. A good example is how long it took Digene to get traction with cervical cancer screening. By its nature Ovarian cancer is a far more difficult space and scientific literature is probably 10-15 years behind cervical cancer in acceptance of screening.
As a screening tool the 2 key data aspects are sensitivity and negative predictive value (NPV)...forget the rest...I dont understand why HTX keeps on harping on about "diagnostic efficiency"
HTX Price at posting:
11.5¢ Sentiment: None Disclosure: Held